Active ingredient comparison

Infliximab products and price references.

Infliximab appears in 5 brand or manufacturer-labeled product profiles in the US Med Access catalog, covering 138 dated package references. European estimated medicine cost references currently range from €2,480.44 – €5,615.98. A shared ingredient does not make different products, strengths, dosage forms or packages interchangeable.

Product profiles5
Package references138
European references€2,480.44 – €5,615.98
Last source review

Infliximab listed products

Open the exact profile before comparing figures. Brand, manufacturer, authorization, dosage form, strength and package quantity can differ even when the named active ingredient is the same.

Brand or productCategoryPackagesEuropean referenceComparable U.S. cashProfile
FlixabiMultiple EU-listed suppliers Immunology 15 €2,599.65 to €4,759.58 Not listed Open profile →
InflectraPfizer Pharma GmbH Immunology 4 €2,606.39 to €4,733.00 Not listed Open profile →
RemicadeMultiple EU-listed suppliers Immunology 23 €2,594.82 to €4,765.21 Not listed Open profile →
RemsimaMultiple EU-listed suppliers Immunology 88 €2,480.44 to €5,615.98 Not listed Open profile →
ZesslyMultiple EU-listed suppliers Immunology 8 €2,606.39 to €4,775.77 Not listed Open profile →

Compare identity
before price.

Open each product profile and match the intended brand, manufacturer, strength, dosage form and package quantity. Only compare cost references after the products are meaningfully comparable.

01

Confirm the intended product

A shared active ingredient can appear across products with different labeling, indications, strengths and market status.

02

Normalize the package

Compare equivalent quantities and retain the original package description beside any unit-level calculation.

03

Request a current review

Price, availability, source status, exchange rates and route requirements can change after publication.

Need a Infliximab package comparison?

Share the intended brand, strength, dosage form, quantity, destination and organization type. No substitution, supply or import outcome is guaranteed.

Request a comparison   ↗